Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their proprietary technology to provide the world’s first stain-free AI-driven biopsy and tissue analysis focused on the diagnosis of fibrosis and cancer, and his thoughts on the Singaporean healthcare start-up ecosystem.
We are the only company that digitizes stain-free biopsies, using our proprietary biophotonics technology and platform for stain-free AI-based digital pathology. This is a huge differentiator
